Ann Rheum Dis

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

Annals of the Rheumatic Diseases 2006;65:1168-1174; doi:10.1136/ard.200X.046896
Copyright © 2006 BMJ Publishing Group Ltd & European League Against Rheumatism

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Alarcón, G S
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Alarcón, G S

EXTENDED REPORT

Systemic lupus erythematosus in a multiethnic cohort: LUMINA XXXV. Predictive factors of high disease activity over time

G S Alarcón 1, J Calvo-Alén 2, G McGwin, Jr 2, A G Uribe 3, S M A Toloza 4, J M Roseman 3, M Fernández 5, B J Fessler 1, L M Vilá 4, C Ahn 5, F K Tan 5, J D Reveille 5 for the LUMINA Study Group

1 Department of Medicine, Division of Clinical Immunology and Rheumatology, School of Medicine, The University of Alabama at Birmingham, Birmingham, Alabama, USA
2 Department of Surgery, Section of Trauma, Burns, and Critical Care, School of Medicine
3 Department of Epidemiology, School of Public Health
4 Department of Internal Medicine, Division of Rheumatology, University of Puerto Rico, San Juan, Puerto Rico
5 Department of Medicine, Division of Rheumatology, The University of Texas-Health Science Center at Houston, Houston, Texas, USA

Correspondence to:
Correspondence to:
G S Alarcón
830 FOT, The University of Alabama at Birmingham, Birmingham, AL 35294, USA; graciela.alarcon{at}ccc.uab.edu

Aim: To ascertain the predictive factors of high levels of disease activity in systemic lupus erythematosus (SLE).

Patients and methods: Patients with SLE (American College of Radiology criteria), aged >=16 years, with disease duration <=5 years and of Hispanic (Texas and Puerto Rico), African American and Caucasian ethnicities, were included. The outcome was high disease activity at any time (Systemic Lupus Activity Measure—Revised >10). A basic multivariable model (including age, sex, ethnicity, health insurance, social support, abnormal illness-related behaviours, helplessness and prior disease activity) was first examined. Additional models were built by including other variables.

Results: 554 patients (100 Hispanics from Texas, 94 Hispanics from Puerto Rico, 199 African Americans, 161 Caucasians) and 2366 visits were analysed; 47% of the patients and 29% of the visits met the definition of high disease activity (more common among African Americans (72.0%) and Hispanics from Texas (71.3%) than among Caucasians (43.9%) and Hispanics from Puerto Rico (31.9%)). Variables found to predict high levels of disease activity were Hispanic (from Texas) and African American ethnicities, lack of health insurance, helplessness, abnormal illness-related behaviours and poor social support; age was negatively associated with high levels of disease activity. African admixture and anti-double-stranded DNA antibodies also predicted high levels of disease activity, as did prior disease activity. None of the human leucocyte antigen variables were retained in the models.

Conclusions: Socioeconomic–demographic (age, ethnicity, health insurance), behavioural and psychological variables are important mediators of high levels of disease activity in SLE during its course. Interventions aimed at modifiable factors may improve the outcomes of SLE.


Abbreviations: AIM, ancestry informative marker; CODIS, Combined DNA Index System; dsDNA, double-stranded DNA; GEE, generalized estimating equation; SLAM-R, Systemic Lupus Activity Measure—Revised; SLE, systemic lupus erythematosus; SLEDAI, Systemic Lupus Erythematosus Disease Activity Index







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2006 BMJ Publishing Group Ltd & European League Against Rheumatism